Skip to content
Search

Latest Stories

PDA’s new awareness factsheet advises pharmacists on how to deal with stress at workplace

The Pharmacists’ Defence Association (PDA) is playing a vital role in helping pharmacists who are dealing with stress at the workplace. It launched its new awareness factsheet ‘It’s Time to Address Stress’ last week.

The factsheet looks at the causes and symptoms of stress in the workplace and provides advice on ways pharmacists can access support and improve working conditions.


The association said that it recognizes the well-being services offered by employers and specialist charities such as the PDA’s charity partner Pharmacist Support play an important part in helping pharmacists who may be experiencing stress.

However, the PDA is also committed to working with members to challenge employers to provide well workplaces and to help them to make real impact changes. This can be done by addressing the causes of stress and fulfilling their responsibilities to their employees.

It added: “Under the management of Health and Safety at Work Regulations 1999, employers are required by law to protect employees from harm. Their legal obligations include identifying hazards and risks and implementing ways to reduce or eliminate them. The PDA’s new factsheet highlights the importance of employers recognizing the hazards causing stress as the health and safety issues they are.”

During the PDA’s 75-minute event attendees discussed the realities of how stress impacts their working lives and reflected on how they can work with employers to improve this.

The event referenced the earlier Health and Safety Executive (HSE) Stress and Wellbeing surveys undertaken by the PDA within community and hospital settings. The PDA utilized the HSE Management Standards for context and members shared their daily experiences across community, hospital, and primary care settings including the demands placed on them through short staffing, additional workloads, and often unsupportive organizational structures.

One of the PDA members said: “The practice I work in has recently lost a valued team member through the stress she was under, and there is no-one to replace her for the next few months while they recruit. As no-one else is trained to do her role, her work coming to me and the other pharmacist – on top of our full-to-bursting clinics and admin responsibilities. Breaks are a thing of the past at the moment!

“I think there is a lack of recognition that regardless of how much work there is to be done, there is only so much that can physically be done. Being told that you’ll just have to ‘step up’ is not helpful or realistic.

“The challenge for pharmacists in community is that so much of the time you are the sole pharmacist in the building – no disrespect to the colleagues we work with, but when you are the only pharmacist, it is isolating.”

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Pharmacy First: Government confirms £215 million boost to realise its full potential

From April 2025, the consultation fee for Pharmacy First Minor Illness and Clinical Pathways will rise from £15 to £17.

‘Pharmacy First hasn't realised its full potential,’ says Stephen Kinnock

Health Minister Stephen Kinnock has acknowledged that Pharmacy First has huge potential, noting that the service “hasn't realised its full potential.”

As part of efforts to enhance the service, Kinnock yesterday (30) announced £215 million in additional funding for Pharmacy First and other Primary Care Access Recovery Plan services.

Keep ReadingShow less
New CPCF funding: “This is the best deal community pharmacy has had in a decade”

This new funding settlement marks a significant step forward in addressing the long term underinvestment in community pharmacy, says RPS England chair Tase Oputu

Pharmacy bodies hail new funding settlement as ‘best deal for community pharmacy in a decade’

Pharmacy bodies have welcomed the new funding settlement for community pharmacies, highlighting its potential to enhance patient access to care and medicines while addressing a decade of underinvestment in the sector.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a record £3.073 billion funding package for 2025/26, along with an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less